azauridine has been researched along with Remission, Spontaneous in 2 studies
Azauridine: A triazine nucleoside used as an antineoplastic antimetabolite. It interferes with pyrimidine biosynthesis thereby preventing formation of cellular nucleic acids. As the triacetate, it is also effective as an antipsoriatic.
Remission, Spontaneous: A spontaneous diminution or abatement of a disease over time, without formal treatment.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pratt, CB | 1 |
| Roberts, D | 1 |
| Shanks, E | 1 |
| Warmath, EL | 1 |
| Jackson, R | 2 |
| Fleming, I | 1 |
| Simone, J | 1 |
| Johnson, W | 1 |
| Walters, T | 1 |
| Mason, C | 1 |
2 other studies available for azauridine and Remission, Spontaneous
| Article | Year |
|---|---|
Asparaginase in combination chemotherapy for remission induction of childhood acute lymphocytic leukemia.
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Azauridine; Bone Marrow; Bone Marrow Cells; Child; | 1973 |
Proceedings: Splenectomy and chemotherapy in acute myelocytic leukemia of childhood.
Topics: Adolescent; Adult; Age Factors; Azauridine; Child; Child, Preschool; Cytarabine; Drug Therapy, Combi | 1974 |